full

Ep. 75 - Professionals: Dr. Michael Canney, Chief Scientific Officer at Carthera - Cutting edge ultrasound technology for Gliobalstoma treatment

Published on: 27th May, 2025

This week on the Let’s Talk F*ng Cancer podcast, we’re diving headfirst into the future of brain cancer treatment with none other than Dr. Michael Canney, Chief Scientific Officer at Carthera — the minds behind the groundbreaking SonoCloud-9®. 🧠⚡

Carthera is revolutionizing how we fight glioblastoma, one of the most aggressive brain cancers out there. With their implantable ultrasound device that opens the blood-brain barrier, they’re giving chemo a chance to actually work — and giving patients a fighting shot. 🙌💊

This isn’t just innovation. It’s a f*ng game-changer.

👂 Tune in to hear how Dr. Canney and the Carthera team are pushing science forward and giving new hope to those battling GBM.

🎧 Available now wherever you get your podcasts!

#LetsTalkFuckingCancer #Glioblastoma #BrainCancer #Carthera #SonoCloud9 #DrMichaelCanney #CancerPodcast #GBM #BreakthroughScience #MedicalInnovation #FuckCancer

Sonobird Clinical Trial

Carthera Advanced Brain Therapy

NeuroNews: Carthera 2023

NeuroNews: Carthera 2024

Biospace: Milestone in SONOBIRD pivotal trial April 2025

Medical Design and Development: Trial begins April 2025

Next Episode All Episodes Previous Episode
Show artwork for Let's talk F*ng Cancer

About the Podcast

Let's talk F*ng Cancer
Trailer
Welcome to the Let's Talk F*ng Cancer podcast. Where we will be covering all things in the cancer world. With our 4 monthly topics covering professionals from the cancer world, tips& tricks to get through your chemotherapy, radiation and more. We will also be having spotlight episodes speaking with cancer survivors and thrivers, as well as a grief and remembrance segment focusing on saying the names of loved ones passed.

About your host

Profile picture for Colette Hoang

Colette Hoang